Parnell Pharmaceuticals (OTCMKTS:PARNF) Shares Up 37.5% – Should You Buy?

Parnell Pharmaceuticals Holdings Ltd (OTCMKTS:PARNF) was up 37.5% on Thursday . The company traded as high as $0.19 and last traded at $0.17. Approximately 10,000 shares were traded during mid-day trading, a decline of 53% from the average daily volume of 21,500 shares. The stock had previously closed at $0.12.

Parnell Pharmaceuticals Stock Up 37.5 %

Parnell Pharmaceuticals Company Profile

Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal – U.S., Production Animal – Rest of World, and Manufacturing Operations.